Learn More
PURPOSE Racotumomab-alum is an anti-idiotype vaccine targeting the NeuGcGM3 tumor-associated ganglioside. This clinical trial was conducted to provide a preliminary estimate of efficacy and safety of(More)
Negative results are frequent using anti-TNFα antibodies in sepsis models and clinical trials. Different prophylactic doses of anti-TNFα F(ab')2 antibody fragments were compared for the prevention of(More)